Inke S.A: APIs manufacturing plant.
01 1INKE SA
02 1Dr. Reddy's Laboratories Limited
03 1Glaxo Wellcome Manufacturing Pte. Ltd
04 1HIKAL LIMITED
05 1Ipca Laboratories Limited
06 1ScinoPharm Taiwan Ltd.
07 1TAPI Hungary Industries Kft.
08 1Teva Pharmaceutical Works Private Limited Company
01 1ONDANSETRON
02 1ONDANSETRON BASE
03 5Ondansetron
04 1ondansetron
01 3India
02 1Israel
03 1Spain
04 1Taiwan
05 1United Kingdom
06 1Blank
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0008
Start Marketing Date : 2009-08-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-050
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52482-019
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66651-904
Start Marketing Date : 2015-01-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1191
Start Marketing Date : 2010-08-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-2118
Start Marketing Date : 2004-11-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51846-1033
Start Marketing Date : 2017-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84671-1033
Start Marketing Date : 2017-11-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Ondansetron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ondansetron, including repackagers and relabelers. The FDA regulates Ondansetron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ondansetron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ondansetron manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ondansetron supplier is an individual or a company that provides Ondansetron active pharmaceutical ingredient (API) or Ondansetron finished formulations upon request. The Ondansetron suppliers may include Ondansetron API manufacturers, exporters, distributors and traders.
click here to find a list of Ondansetron suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ondansetron as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ondansetron API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ondansetron as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ondansetron and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ondansetron NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ondansetron suppliers with NDC on PharmaCompass.
We have 7 companies offering Ondansetron
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
